153 related articles for article (PubMed ID: 38183091)
1. Recurrent Vulvovaginal Candidiasis: Assessing the relationship between feminine/vaginal washes and other factors among Ghanaian women.
Otoo-Annan E; Senoo-Dogbey VE
BMC Public Health; 2024 Jan; 24(1):100. PubMed ID: 38183091
[TBL] [Abstract][Full Text] [Related]
2. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes.
Yano J; Sobel JD; Nyirjesy P; Sobel R; Williams VL; Yu Q; Noverr MC; Fidel PL
BMC Womens Health; 2019 Mar; 19(1):48. PubMed ID: 30925872
[TBL] [Abstract][Full Text] [Related]
3. Recurrent vulvovaginal candidiasis.
Blostein F; Levin-Sparenberg E; Wagner J; Foxman B
Ann Epidemiol; 2017 Sep; 27(9):575-582.e3. PubMed ID: 28927765
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life as measured with the Short-Form 36 (SF-36) questionnaire in patients with recurrent vulvovaginal candidiasis.
Zhu YX; Li T; Fan SR; Liu XP; Liang YH; Liu P
Health Qual Life Outcomes; 2016 Apr; 14():65. PubMed ID: 27129474
[TBL] [Abstract][Full Text] [Related]
5. Vaginal microbiological flora and sexually transmitted diseases in women with recurrent or current vulvovaginal candidiasis.
Zdolsek B; Hellberg D; Fröman G; Nilsson S; Mårdh PA
Infection; 1995; 23(2):81-4. PubMed ID: 7622268
[TBL] [Abstract][Full Text] [Related]
6. Influence of recurrent vulvovaginal candidiasis on quality of life issues.
Fukazawa EI; Witkin SS; Robial R; Vinagre JG; Baracat EC; Linhares IM
Arch Gynecol Obstet; 2019 Sep; 300(3):647-650. PubMed ID: 31270690
[TBL] [Abstract][Full Text] [Related]
7. Survey of incidence, lifetime prevalence, and treatment of self-reported vulvovaginal candidiasis, United States, 2020.
Benedict K; Singleton AL; Jackson BR; Molinari NAM
BMC Womens Health; 2022 May; 22(1):147. PubMed ID: 35538480
[TBL] [Abstract][Full Text] [Related]
8. [Local humoral immunity in vulvovaginal candidiasis].
Amouri I; Hadrich I; Abbes S; Sellami H; Ayadi A
Ann Biol Clin (Paris); 2013; 71(2):151-5. PubMed ID: 23587578
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey.
Foxman B; Muraglia R; Dietz JP; Sobel JD; Wagner J
J Low Genit Tract Dis; 2013 Jul; 17(3):340-5. PubMed ID: 23486072
[TBL] [Abstract][Full Text] [Related]
10. Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis.
Ge G; Yang Z; Li D; Zhang N; Chen B; Shi D
Front Immunol; 2022; 13():959740. PubMed ID: 35967437
[TBL] [Abstract][Full Text] [Related]
11. The dynamic changes of vaginal microecosystem in patients with recurrent vulvovaginal candidiasis: a retrospective study of 800 patients.
Yue XA; Chen P; Tang Y; Wu X; Hu Z
Arch Gynecol Obstet; 2015 Dec; 292(6):1285-94. PubMed ID: 26041326
[TBL] [Abstract][Full Text] [Related]
12. Treatment for recurrent vulvovaginal candidiasis (thrush).
Cooke G; Watson C; Deckx L; Pirotta M; Smith J; van Driel ML
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD009151. PubMed ID: 35005777
[TBL] [Abstract][Full Text] [Related]
13. Analysis of pathogenic factors of Candida albicans and the effect of vaginal immunization on recurrent vulvovaginal candidiasis in mice.
Shao MK; Qi WJ; Hou MY; Luo DD
J Obstet Gynaecol Res; 2022 Mar; 48(3):857-865. PubMed ID: 34970814
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
[TBL] [Abstract][Full Text] [Related]
15. A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana.
Adjapong G; Hale M; Garrill A
Med Mycol; 2017 Aug; 55(6):686-689. PubMed ID: 27838642
[TBL] [Abstract][Full Text] [Related]
16. Highlights Regarding Host Predisposing Factors to Recurrent Vulvovaginal Candidiasis: Chronic Stress and Reduced Antioxidant Capacity.
Akimoto-Gunther L; Bonfim-Mendonça Pde S; Takahachi G; Irie MM; Miyamoto S; Consolaro ME; Svidzinsk TI
PLoS One; 2016; 11(7):e0158870. PubMed ID: 27415762
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of sexual function in Brazilian women with recurrent vulvovaginal candidiasis and localized provoked vulvodynia.
Giraldo PC; Polpeta NC; Juliato CR; Yoshida LP; do Amaral RL; Eleutério Junior J
J Sex Med; 2012 Mar; 9(3):805-11. PubMed ID: 22214370
[TBL] [Abstract][Full Text] [Related]
18. HLA-DRB1 alleles as predisposing and resisting factor in women suffering from vulvovaginal candidiasis.
Razavi T; Falahati M; Teimourian S; Farahyar S; Babaei V; Majdabadi N
J Mycol Med; 2021 Dec; 31(4):101200. PubMed ID: 34492482
[TBL] [Abstract][Full Text] [Related]
19. Recurrent vulvo-vaginal candidiasis in Abidjan (Côte d'Ivoire): Aetiology and associated factors.
Djohan V; Angora KE; Vanga-Bosson AH; Konaté A; Kassi KF; Kiki-Barro PCM; Bedia-Tanoh AV; Miezan S; Menan EIH; Yavo W
J Mycol Med; 2019 Jun; 29(2):127-131. PubMed ID: 31010729
[TBL] [Abstract][Full Text] [Related]
20. Frequency of interleukin-4 (IL-4) -589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannose-binding lectin in women with recurrent vulvovaginal candidiasis.
Babula O; Lazdāne G; Kroica J; Linhares IM; Ledger WJ; Witkin SS
Clin Infect Dis; 2005 May; 40(9):1258-62. PubMed ID: 15825027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
